These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7943773)

  • 1. In vitro reversal of heparin effect with heparinase: evaluation with whole blood prothrombin time and activated partial thromboplastin time in cardiac surgical patients.
    Despotis GJ; Summerfield AL; Joist JH; Goodnough LT; Santoro SA; Zimmermann JJ; Lappas DG
    Anesth Analg; 1994 Oct; 79(4):670-4. PubMed ID: 7943773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor.
    Harenberg J; Reichel T; Malsch R; Hirsh J; Rustagi P
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):453-8. PubMed ID: 8839997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic elimination of heparin from plasma for activated partial thromboplastin time and prothrombin time testing.
    van den Besselaar AM; Meeuwisse-Braun J
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):635-8. PubMed ID: 8218862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.
    Despotis GJ; Santoro SA; Spitznagel E; Kater KM; Barnes P; Cox JL; Lappas DG
    Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparinase: in vivo activity and immunogenicity in rabbits.
    Klein MD; Drongowski RA; Linhardt RJ; Cooney CL; Langer RS
    J Lab Clin Med; 1983 Nov; 102(5):828-37. PubMed ID: 6631173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor.
    Despotis GJ; Hogue CW; Santoro SA; Joist JH; Barnes PW; Lappas DG
    Crit Care Med; 1995 Oct; 23(10):1674-9. PubMed ID: 7587232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aprotinin prolongs whole blood activated partial thromboplastin time but not whole blood prothrombin time in patients undergoing cardiac surgery.
    Despotis GJ; Alsoufiev A; Goodnough LT; Lappas DG
    Anesth Analg; 1995 Nov; 81(5):919-24. PubMed ID: 7486078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agreements between the prothrombin times of blood treated In Vitro with heparinase during cardiopulmonary bypass (CPB) and blood sampled after CPB and systemic protamine.
    Ho AM; Lee A; Ling E; Daly A; Teoh K; Warkentin TE
    Anesth Analg; 2003 Jan; 96(1):15-20, table of contents. PubMed ID: 12505916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of normal versus abnormal activated partial thromboplastin time and prothrombin time after cardiopulmonary bypass.
    Nuttall GA; Oliver WC; Beynen FM; Santrach PJ; Strickland RA; Murray MJ
    J Cardiothorac Vasc Anesth; 1995 Aug; 9(4):355-61. PubMed ID: 7579102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative measurement of activated partial thromboplastin time and prothrombin time by a portable laser photometer in patients following cardiopulmonary bypass.
    Nuttall GA; Oliver WC; Beynen FM; Dull JJ; Murray MJ; Nichols WL
    J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):402-9. PubMed ID: 8400094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aprotinin and heparin monitoring during cardiopulmonary bypass.
    Hunt BJ; Segal H; Yacoub M
    Circulation; 1992 Nov; 86(5 Suppl):II410-2. PubMed ID: 1385011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay.
    Tuman KJ; McCarthy RJ; Djuric M; Rizzo V; Ivankovich AD
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):144-9. PubMed ID: 8204806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
    Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL
    Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of heparinase 1 and protamine on platelet reactivity.
    Ammar T; Fisher CF
    Anesthesiology; 1997 Jun; 86(6):1382-6. PubMed ID: 9197309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
    Levin AI; Heine AM; Coetzee JF; Coetzee A
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparative Study of Point-of-Care Prothrombin Time in Cardiopulmonary Bypass Surgery.
    Okabayashi S; Ogawa S; Tanaka KA; Nishiyama T; Takeshita S; Nakayama Y; Nakajima Y; Sawa T; Mizobe T
    J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1609-1614. PubMed ID: 29395816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin degradation by a novel microbial heparinase.
    Böhmer LH; Pitout MJ; Allcock JL; Visser L
    Thromb Res; 1990 Nov; 60(4):331-5. PubMed ID: 2087692
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin neutralization with methylene blue, hexadimethrine, or vancomycin after cardiopulmonary bypass.
    Kikura M; Lee MK; Levy JH
    Anesth Analg; 1996 Aug; 83(2):223-7. PubMed ID: 8694296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.